Treatment

Seaside Therapeutics Discontinues Arbaclofen (STX209) Extension Study

Source: 
The Boston Globe
Date Published: 
May 31, 2013
Abstract: 

Seaside Therapeutics has discontinued their extension study of Arbaclofen (STX209), a drug that showed promise in treating social impairment related to Fragile X syndrome.

How Can Immigrant Families Get Help For Their Autistic Child

Source: 
ASF Blog
Date Published: 
May 24, 2013
Abstract: 

Guest blogger Marcela De Vivo shares insight on some of the difficulties immigrant families face when getting help for their child with autism in this week's ASF blog post.

Environmental Enrichment as an Effective Treatment for Autism: A Randomized Controlled Trial

Source: 
Behavioral Neuroscience
Date Published: 
May 20, 2013
Abstract: 

Researchers at University of California Irvine conducted a randomized controlled trial of sensorimotor enrichment in young boys with ASD. Behavioral and cognitive improvements in the children who received sensorimotor therapy suggest that it may be a promising treatment for ASD symptoms. The group is now conducting a larger trial that includes girls.

Cognitive Enhancement Therapy for Adults with Autism Spectrum Disorder: Results of an 18-month Feasibility Study

Source: 
Journal of Autism and Developmental Disorders
Date Published: 
April 26, 2013
Abstract: 

New findings from a small pilot study suggest cognitive enhancement therapy is a feasible and effective intervention for cognitive impairments in verbal adults with ASD. Adult participants were highly satisfied with the therapy and treatment attendance was high, indicating their willingness to participate in and commit to an intervention that they considered useful.

Brief Report: Is Cognitive Rehabilitation Needed in Verbal Adults with Autism? Insights from Initial Enrollment in a Trial of Cognitive Enhancement Therapy

Source: 
Journal of Autism and Developmental Disorders
Date Published: 
February 5, 2013
Abstract: 

Early results from this pilot trial of cognitive enhancement therapy (CET) indicate that despite above-average intelligence, verbal adults with ASD can have significantly impaired neurocognition and social cognition. The authors suggest CET, which is designed to remediate both social and non-social deficits through computer-based neurocognitive training, could be useful for cognitive rehabilitation in this population.

Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey

Source: 
School Mental Health
Date Published: 
March 1, 2013
Abstract: 

This study examined school-based medication monitoring in children with ASD. Researchers found that less than half of teachers of medicated students were aware that students were taking medication and no teachers were communicating with prescribing physicians about student behavior and side effects. Since monitoring medication across settings helps physicians assess drug safety and effectiveness, the authors argue for increased communication among professionals.

Why Are There So Many Unsubstantiated Treatments in Autism?

Source: 
Research in Autism Spectrum Disorders
Date Published: 
December 27, 2012
Abstract: 

An estimated 32-92% of parents use complementary/alternative treatments for their children with ASD despite the lack of scientific evidence for the efficacy of these methods. In this article, researchers issue a call for a standardized way to select and evaluate treatments. Barriers to successful treatment, including high costs, limited availability, parental compliance and poor recommendations from professionals are discussed.

Mothers Fight to Pass Ava's Law for Autism Coverage

Source: 
CNN
Date Published: 
March 12, 2013
Abstract: 

"If passed, Ava's Law would require insurance companies to pay for "evidence-driven treatment" -- or treatment that's been scientifically shown to help kids with an autism spectrum disorder. The law would not affect the self-insured plans offered by bigger companies, which cover about 60% of insured people in the state, according to the Georgia Office of Insurance."